As of Nov 2, 2026: Paul Edward Kelly (COO, RLMD) reported 1 buy for $198K in the last 12 months (Form 4). RLMD's Quality Score is 1. Scores as of 8:57 PM ET, 15 minutes behind.

Paul Edward Kelly

Chief Operating Officer of Relmada Therapeutics

1 stock trade in the last 12 months, shares they bought or sold themselves (not grants or options).

Bought$198K12 months Sold$012 months Last filedNov 6, 2025a buy

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Paul Edward Kelly reported

Newest first, as filed

Stock	Trade	Amount	Trade	Shares	Traded Filed
RLMDRelmada Therapeutics	Buy	$198Kat $2.20	Buy$198Kat $2.20	90,000 at $2.20	Nov 5, 2025filed Nov 6, 2025SEC filing

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See the tradeSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Paul Edward Kelly's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
RLMDRelmada TherapeuticsCOO	Chief Operating Officerfiled Nov 6, 2025	1	1

Alerts for Paul Edward Kelly

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Nov 6, 2025.

Free to reuse with a link to this page.

How to cite

Breakaway, Paul Edward Kelly: Chief Operating Officer at RLMD, Nov 6, 2025, getbreakaway.com/insiders/paul-edward-kelly

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at Relmada Therapeutics

Insider trades by person